Back to Search
Start Over
Evolving Landscape of Biologic Therapy for Pediatric Psoriasis.
- Source :
-
Dermatologic clinics [Dermatol Clin] 2024 Jul; Vol. 42 (3), pp. 377-386. Date of Electronic Publication: 2024 Mar 27. - Publication Year :
- 2024
-
Abstract
- Pediatric psoriasis is a chronic inflammatory skin condition. Current treatment modalities include topical medications, phototherapy, and systemic drugs, including biological agents. In cases of moderate-to-severe psoriasis recalcitrant to other therapies, biological therapies are often an attractive option given their dosing schedules, safety profiles, and need for less frequent laboratory monitoring, when compared with traditional systemic therapies. This article reviews biological treatment options approved for pediatric psoriasis and identifies others actively under investigation.<br />Competing Interests: Disclosure The authors have no disclosures, conflicts of interest, or funding sources to declare.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Child
Biological Therapy
Infliximab therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Etanercept therapeutic use
Antibodies, Monoclonal therapeutic use
Rituximab therapeutic use
Interleukin 1 Receptor Antagonist Protein therapeutic use
Alefacept
Certolizumab Pegol therapeutic use
Psoriasis drug therapy
Psoriasis therapy
Adalimumab therapeutic use
Biological Products therapeutic use
Ustekinumab therapeutic use
Dermatologic Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1558-0520
- Volume :
- 42
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Dermatologic clinics
- Publication Type :
- Academic Journal
- Accession number :
- 38796269
- Full Text :
- https://doi.org/10.1016/j.det.2024.02.003